Company intelligence / Profile preview

Obloo Ventures

Ownership: Private
Development stage: Other

Overview

Obloo Ventures is an active European venture capital operator specializing in deep tech investments across multiple sectors including healthcare/life sciences. It has developed proprietary methodologies for technology transfer and supports startups from proof-of-concept through development. Its portfolio includes innovative companies such as Sibylla Biotech (preclinical small molecule degraders) and QuantaBrain (AI-based brain biomarker detection), among others.

Therapeutic areas: OncologyNeurology
Modalities: Small moleculeAI-driven drug discovery
Industry: Investors

Partnerships

CINECA (for computational infrastructure around Leonardo HPC)Lean Experience FactoryTakeda PharmaceuticalOno Pharmaceutical

Beyond the preview

Go deeper on Obloo Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obloo Ventures.

Explore the full profile